*Biden budget highlights: Lots of spending, taxing the rich*
President Joe Biden's $6 trillion budget proposal offers major new initiatives like a child and elder care subsidies, generous tax credits for families and the working poor, and free community college. It also promises politically freighted tax increases on the wealthy and corporations and would give domestic Cabinet departments significantly bigger budget increases than the Pentagon.
But like all presidential budget plans, Biden's proposal needs the approval of lawmakers, who can change the allotments and dollar figures.
Here are some other things to keep in mind about Biden's budget:
*Lots of spending*
This year's $6 trillion spending total fueled by ongoing COVID-19 relief efforts is actually down from a projection of $7.2 trillion for the budget year ending in September. But it's sharply higher than the pre-pandemic $4.4 trillion tally of 2019 and fueled by promises of government help for crushing child care, college, health care and elder care costs. But the nation's huge defense budget would get minimal increases, angering Republicans whose votes Biden needs.
*Taxing business and the rich*
Biden promises $2 trillion in corporate tax hikes, including an increase from 21 percent to 28 percent in the corporate rate and restoring the top individual tax bracket from 37 percent to 39.6 percent. Capital gains taxes would increase for wealthier investors, and inherited capital gains would no longer be tax-free. It would extend Democrats' generous increase in the per-child tax credit from $2,000 to $3,600 for children up to 6 years old and $3,000 for older children. It would also crack down on unpaid taxes by boosting reporting and enforcement.
*Barrels of red ink*
Several rounds of pandemic relief swelled last year's deficit to $3.1 trillion, and the U.S. is on track for a $3.7 trillion deficit this year, which means a total national debt exceeding $30 trillion within a few months. While deficits would be cut roughly in half, to $1.8 trillion, in the budget year starting in October, they would remain well above levels that mainstream economists have believed to be sustainable. Annual interest payments on all of that Treasury borrowing would almost double in the next five years from about $300 billion now to $581 billion in 2027.
*Iffy prospects in congress*
Democrats control Congress by the narrowest of margins and could theoretically pass Biden's tax increases and many of his bold spending plans under special budget rules that prevent a GOP Senate filibuster. But it only takes a single Democratic defection to mess things up, and there's ample resistance to Biden's full corporate tax increase and higher taxes on capital gains. Smaller tax increases would mean Democrats would have to scale back their ambitions on spending. And Senate Republicans are sure to bring Biden's high-flying hopes for annual nondefense appropriations back to Earth by insisting on spending increases for the Pentagon that are comparable to domestic agencies.
*Cautious economic projections*
Some of Biden's predecessors, including former President Donald Trump, were guilty of juicing economic projections to make their budget numbers work. But the Biden team appears more cautious, projecting long-term economic growth of about 2 percent after a 5.2 percent boost this year and a 3.2 percent increase in 2022. Consumer prices, which are currently spiking, are seen as remaining in check, at about 2 percent inflation each year
President Joe Biden's $6 trillion budget proposal offers major new initiatives like a child and elder care subsidies, generous tax credits for families and the working poor, and free community college. It also promises politically freighted tax increases on the wealthy and corporations and would give domestic Cabinet departments significantly bigger budget increases than the Pentagon.
But like all presidential budget plans, Biden's proposal needs the approval of lawmakers, who can change the allotments and dollar figures.
Here are some other things to keep in mind about Biden's budget:
*Lots of spending*
This year's $6 trillion spending total fueled by ongoing COVID-19 relief efforts is actually down from a projection of $7.2 trillion for the budget year ending in September. But it's sharply higher than the pre-pandemic $4.4 trillion tally of 2019 and fueled by promises of government help for crushing child care, college, health care and elder care costs. But the nation's huge defense budget would get minimal increases, angering Republicans whose votes Biden needs.
*Taxing business and the rich*
Biden promises $2 trillion in corporate tax hikes, including an increase from 21 percent to 28 percent in the corporate rate and restoring the top individual tax bracket from 37 percent to 39.6 percent. Capital gains taxes would increase for wealthier investors, and inherited capital gains would no longer be tax-free. It would extend Democrats' generous increase in the per-child tax credit from $2,000 to $3,600 for children up to 6 years old and $3,000 for older children. It would also crack down on unpaid taxes by boosting reporting and enforcement.
*Barrels of red ink*
Several rounds of pandemic relief swelled last year's deficit to $3.1 trillion, and the U.S. is on track for a $3.7 trillion deficit this year, which means a total national debt exceeding $30 trillion within a few months. While deficits would be cut roughly in half, to $1.8 trillion, in the budget year starting in October, they would remain well above levels that mainstream economists have believed to be sustainable. Annual interest payments on all of that Treasury borrowing would almost double in the next five years from about $300 billion now to $581 billion in 2027.
*Iffy prospects in congress*
Democrats control Congress by the narrowest of margins and could theoretically pass Biden's tax increases and many of his bold spending plans under special budget rules that prevent a GOP Senate filibuster. But it only takes a single Democratic defection to mess things up, and there's ample resistance to Biden's full corporate tax increase and higher taxes on capital gains. Smaller tax increases would mean Democrats would have to scale back their ambitions on spending. And Senate Republicans are sure to bring Biden's high-flying hopes for annual nondefense appropriations back to Earth by insisting on spending increases for the Pentagon that are comparable to domestic agencies.
*Cautious economic projections*
Some of Biden's predecessors, including former President Donald Trump, were guilty of juicing economic projections to make their budget numbers work. But the Biden team appears more cautious, projecting long-term economic growth of about 2 percent after a 5.2 percent boost this year and a 3.2 percent increase in 2022. Consumer prices, which are currently spiking, are seen as remaining in check, at about 2 percent inflation each year
TiE DelhiNCR is organising a vaccination camp (paid) for 18+ years between 5th & 10th June. Those interested may register at the following link https://pages.razorpay.com/pl_HGDfo4JEpvGzYr/view
One can chose from Covishield, Covaxin and Sputnik
One can chose from Covishield, Covaxin and Sputnik
Razorpay
Pay for TiE Delhi - NCR Covid Vaccination Camp by THE INDUS ENTREPRENURS - DELHI
Vaccination Date: 9th June 2021. Venue: A-5, 4th Floor, The Edenpark Hotel, Shaheed Jeet Singh Marg, Qutab Institutional Area New Delhi 110067 . Indian Angel Network, E-1, Ground Floor, The Edenpark Hotel, Shaheed Jeet Singh Marg, Qutab Institutional Area…
Bank of Baroda reports Q4 net loss of ₹1,046.5 crore https://www.livemint.com/companies/company-results/bank-of-baroda-reports-standalone-q4-net-loss-of-rs-1-046-5-crore-11622282587553.html
mint
Bank of Baroda reports Q4 net loss of ₹1,046.5 crore
The bank's board has approved raising of additional capital up to ₹5,000 crore.
M&M announces a dividend of Rs 8.75/share for FY21, highest ever dividend to commemorate the 75th year of the Company
*Jefferies: Reliance Industries (RIL IN): Petrochemicals: 50% Upside to Segment Ebitda if Current Spreads Sustain*
Maintain BUY with PT of Rs2580 (30% Upside)
Polymer spreads are at decade-highs on strong downstream demand. Polyester chain spreads, well below decade highs on large capacity addn, are recovering gradually. RIL's petchem portfolio spread is tracking 30% ahead of JEFe. Petchem Ebitda could be c50% ahead of JEFe if current spreads sustain in FY22E. This could drive 14% upside to our consol Ebitda est. Sustained strong performance increases the likelihood of the O2C transaction, in our view. Maintain Buy.
*Attractive post correction, increased likelihood of O2C stake sale*: At the current stock price, valuing the Energy business at long-term average multiples, we are left with Rs 1,150/share as imputed value of RIL’s stake in Jio and Retail. This is in line with the valuation offered by PE funds that bought stakes in Jio and Retail in 1QFY21. In our view, sustained strong petrochemical performance improves the likelihood of O2C stake sale in FY22. This could lead to a reversal of the 40% Nifty underperformance. Our PT (Rs 2,580) represents 30% upside.
Maintain BUY with PT of Rs2580 (30% Upside)
Polymer spreads are at decade-highs on strong downstream demand. Polyester chain spreads, well below decade highs on large capacity addn, are recovering gradually. RIL's petchem portfolio spread is tracking 30% ahead of JEFe. Petchem Ebitda could be c50% ahead of JEFe if current spreads sustain in FY22E. This could drive 14% upside to our consol Ebitda est. Sustained strong performance increases the likelihood of the O2C transaction, in our view. Maintain Buy.
*Attractive post correction, increased likelihood of O2C stake sale*: At the current stock price, valuing the Energy business at long-term average multiples, we are left with Rs 1,150/share as imputed value of RIL’s stake in Jio and Retail. This is in line with the valuation offered by PE funds that bought stakes in Jio and Retail in 1QFY21. In our view, sustained strong petrochemical performance improves the likelihood of O2C stake sale in FY22. This could lead to a reversal of the 40% Nifty underperformance. Our PT (Rs 2,580) represents 30% upside.
🇮🇳 *India Daybook*
🔹 *Stocks in News*
*Metropolis:* Net Profit at Rs 61.0 crore from Rs 15.0 crore, revenue increased to Rs 291.0 crore from Rs 207.0 crore, YoY. (Positive)
*Dixon tech:* Net Profit at Rs 44.26 crore from Rs 27.6 crore, revenue increased to Rs 2110.0 crore from Rs 857.0 crore, YoY. (Positive)
*Honda Power:* Net profit jumped to Rs 15.3 crore from Rs 4.9 crore, while revenue increased to Rs 295.0 crore from Rs 195.0 crore, YoY. (Positive)
*Greenlam:* Net profit at Rs 31.3 crore from Rs 22.9 crore, while revenue seen at Rs 415.0 crore from Rs 324.0 crore, YoY (Positive)
*GSFC:* Net profit at Rs 149.8 crore from Rs 61.8 crore, while revenue seen at Rs 1740.0 crore from Rs 1862.0 crore, YoY. (Positive)
*Phoenix Mills:* Net profit at Rs 65.5 crore from Rs 46.7 crore, while revenue seen at Rs 385.0 crore from Rs 399.0 crore, YoY. (Positive)
*Mangalam Organics:* Net profit at Rs 44.6 crore from Rs 16.3 crore, while total income rose to Rs 96.0 crore from Rs 81.0 crore, YoY. (Positive)
*Redington:* Net profit at Rs 303.4 crore from Rs 126.7 crore, while total income rose to Rs 15503.0 crore from Rs 12666.0 crore, YoY. (Positive)
*GPPL:* Net profit at Rs 6.5 crore from Rs 4.8 crore, while total income rose to Rs 193.4 crore from Rs 161.9 crore, YoY. (Positive)
*Navneet:* Net profit at Rs 18.9 crore from loss of Rs 22.7 crore, while revenue rose to Rs 215.6 crore from Rs 123.0 crore, YoY (Positive)
*SH Kelkar:* Net profit at Rs 53.2 crore from Rs 18.1 crore, while revenue rose to Rs 375.9 crore from Rs 269.7 crore, YoY (Positive)
*Punjab Chemicals:* Net profit at Rs 10.5 crore from Rs 4.7 crore, while revenue rose to Rs 209.5 crore from Rs 106.8 crore, YoY (Positive)
*Siyaram:* Net profit at Rs 58.2 crore from Rs 23.3 crore, while revenue rose to Rs 507.0 crore from Rs 466.8 crore, YoY (Positive)
*Hawkins:* Net profit at Rs 24.0 crore from Rs 9.4 crore, while revenue rose to Rs 245.0 crore from Rs 146.0 crore, YoY (Positive)
*Solar Ind:* Net profit at Rs 95.0 crore from Rs 53.2 crore, while revenue rose to Rs 791.4 crore from Rs 547.5 crore, YoY (Positive)
*UCO Bank:* Net profit at Rs 80.0 crore from Rs 16.8 crore, while Interest Earned at Rs 3566.0 crore from Rs 3742.0 crore, YoY (Positive)
*Stylam Ind:* Net profit at Rs 23.5 crore from loss of Rs 9.2 crore, while revenue rose to Rs 166.5 crore from Rs 105.7 crore, YoY (Positive)
*Eicher Motors:* Net profit rose 72.9 percent to Rs 526.1 crore from Rs 304.3 crore, while revenue increased 33.2 percent to Rs 2,940.3 crore from Rs 2,208.2 crore, YoY. (Positive)
*NOCIL:* Net profit at Rs 37.33 crore in Q4FY21 as against Rs 21.87 crore, while revenue jumped to Rs 321.99 crore from Rs 212.66 crore, YoY (Positive)
*Apollo Hospital:* Company launches a drive-in vaccination programme in Ahmedabad. (Positive)
*Jubilant Pharma:* India Ratings has upgraded Long Term Issuer Rating to ‘IND AA+’ from ‘IND AA’. (Positive)
*TCS:* Recognized as a Leader in AWS Services in the US by ISG (Positive)
*TRIL*: Company receives export order of Transformers amounting to Rs. 84 Crores from GE T&D I. (Positive)
*Telecom Stocks:* Department of Telecom finally allotted 5G spectrum to Airtel, Vodafone Idea and Reliance Jio for 5G trials.. (Positive)
*NLC India:* The company has issued and allotted commercial papers worth Rs 300 crore. (Positive)
*Godrej Agrovet:* CRISIL has re-affirmed its "CRISIL A1+" rating on the Rs.1000 Crore. (Neutral)
*IRB Infra:* Net profit at Rs 98.0 crore from Rs 154.0 crore, while revenue increased to Rs 1606.0 crore from Rs 1584.0 crore, YoY (Neutral)
*Sun Pharma:* Net profit at Rs 894.0 crore versus poll of Rs 1443.0 crore, while revenue increased to Rs 8523.0 crore from Rs 8185.0 crore, YoY (Neutral)
*GIPCL:* Net profit at Rs 43.5 crore from Rs 61.9 crore, while revenue seen at Rs 332.0 crore from Rs 342.0 crore, YoY (Neutral)
*BBL:* Net profit at Rs 13.0 crore from Rs 14.2 crore, while revenue increased to Rs 290.0 crore from Rs 260.0 crore, YoY (Neutral)
🔹 *Stocks in News*
*Metropolis:* Net Profit at Rs 61.0 crore from Rs 15.0 crore, revenue increased to Rs 291.0 crore from Rs 207.0 crore, YoY. (Positive)
*Dixon tech:* Net Profit at Rs 44.26 crore from Rs 27.6 crore, revenue increased to Rs 2110.0 crore from Rs 857.0 crore, YoY. (Positive)
*Honda Power:* Net profit jumped to Rs 15.3 crore from Rs 4.9 crore, while revenue increased to Rs 295.0 crore from Rs 195.0 crore, YoY. (Positive)
*Greenlam:* Net profit at Rs 31.3 crore from Rs 22.9 crore, while revenue seen at Rs 415.0 crore from Rs 324.0 crore, YoY (Positive)
*GSFC:* Net profit at Rs 149.8 crore from Rs 61.8 crore, while revenue seen at Rs 1740.0 crore from Rs 1862.0 crore, YoY. (Positive)
*Phoenix Mills:* Net profit at Rs 65.5 crore from Rs 46.7 crore, while revenue seen at Rs 385.0 crore from Rs 399.0 crore, YoY. (Positive)
*Mangalam Organics:* Net profit at Rs 44.6 crore from Rs 16.3 crore, while total income rose to Rs 96.0 crore from Rs 81.0 crore, YoY. (Positive)
*Redington:* Net profit at Rs 303.4 crore from Rs 126.7 crore, while total income rose to Rs 15503.0 crore from Rs 12666.0 crore, YoY. (Positive)
*GPPL:* Net profit at Rs 6.5 crore from Rs 4.8 crore, while total income rose to Rs 193.4 crore from Rs 161.9 crore, YoY. (Positive)
*Navneet:* Net profit at Rs 18.9 crore from loss of Rs 22.7 crore, while revenue rose to Rs 215.6 crore from Rs 123.0 crore, YoY (Positive)
*SH Kelkar:* Net profit at Rs 53.2 crore from Rs 18.1 crore, while revenue rose to Rs 375.9 crore from Rs 269.7 crore, YoY (Positive)
*Punjab Chemicals:* Net profit at Rs 10.5 crore from Rs 4.7 crore, while revenue rose to Rs 209.5 crore from Rs 106.8 crore, YoY (Positive)
*Siyaram:* Net profit at Rs 58.2 crore from Rs 23.3 crore, while revenue rose to Rs 507.0 crore from Rs 466.8 crore, YoY (Positive)
*Hawkins:* Net profit at Rs 24.0 crore from Rs 9.4 crore, while revenue rose to Rs 245.0 crore from Rs 146.0 crore, YoY (Positive)
*Solar Ind:* Net profit at Rs 95.0 crore from Rs 53.2 crore, while revenue rose to Rs 791.4 crore from Rs 547.5 crore, YoY (Positive)
*UCO Bank:* Net profit at Rs 80.0 crore from Rs 16.8 crore, while Interest Earned at Rs 3566.0 crore from Rs 3742.0 crore, YoY (Positive)
*Stylam Ind:* Net profit at Rs 23.5 crore from loss of Rs 9.2 crore, while revenue rose to Rs 166.5 crore from Rs 105.7 crore, YoY (Positive)
*Eicher Motors:* Net profit rose 72.9 percent to Rs 526.1 crore from Rs 304.3 crore, while revenue increased 33.2 percent to Rs 2,940.3 crore from Rs 2,208.2 crore, YoY. (Positive)
*NOCIL:* Net profit at Rs 37.33 crore in Q4FY21 as against Rs 21.87 crore, while revenue jumped to Rs 321.99 crore from Rs 212.66 crore, YoY (Positive)
*Apollo Hospital:* Company launches a drive-in vaccination programme in Ahmedabad. (Positive)
*Jubilant Pharma:* India Ratings has upgraded Long Term Issuer Rating to ‘IND AA+’ from ‘IND AA’. (Positive)
*TCS:* Recognized as a Leader in AWS Services in the US by ISG (Positive)
*TRIL*: Company receives export order of Transformers amounting to Rs. 84 Crores from GE T&D I. (Positive)
*Telecom Stocks:* Department of Telecom finally allotted 5G spectrum to Airtel, Vodafone Idea and Reliance Jio for 5G trials.. (Positive)
*NLC India:* The company has issued and allotted commercial papers worth Rs 300 crore. (Positive)
*Godrej Agrovet:* CRISIL has re-affirmed its "CRISIL A1+" rating on the Rs.1000 Crore. (Neutral)
*IRB Infra:* Net profit at Rs 98.0 crore from Rs 154.0 crore, while revenue increased to Rs 1606.0 crore from Rs 1584.0 crore, YoY (Neutral)
*Sun Pharma:* Net profit at Rs 894.0 crore versus poll of Rs 1443.0 crore, while revenue increased to Rs 8523.0 crore from Rs 8185.0 crore, YoY (Neutral)
*GIPCL:* Net profit at Rs 43.5 crore from Rs 61.9 crore, while revenue seen at Rs 332.0 crore from Rs 342.0 crore, YoY (Neutral)
*BBL:* Net profit at Rs 13.0 crore from Rs 14.2 crore, while revenue increased to Rs 290.0 crore from Rs 260.0 crore, YoY (Neutral)
*Suryoday Finance:* Net Loss at Rs 43.0 crore from loss of Rs 15.5 crore, while revenue fell to Rs 151.0 crore from Rs 203.0 crore, YoY. (Negative)
🔹 *Eyes 👀 on today*
• Paytm Is Said to Target $3 Billion IPO, Largest Yet in India
o Board plans to meet Friday to formally approve the IPO
• BPCL Privatization Expected Latest by March, CFO Says
o BPCL May Buy 2m Tons/Year of Iranian Oil if Price is Right: CFO
• Top India Drugmaker Misses Profit Estimate on One-Time Cost
o U.S. sales fell in the March qtr but India rose almost 13%
• Forex Trades Helped India RBI Pay Bumper Dividend to Government
• Cyclone Inflicts $2.1 Billion in Damage in India’s West Bengal
• India FY22 Housing Demand Seen Rising 5-10% on WFH Trend: Crisil
• Oil Demand Recovery in Virus-Ravaged India Tough to Predict
• U.S. LNG Exports to India Jump; Robust Deliveries to China
• Twitter Decries India Intimidation, Will Press for Changes
• Toll Collections Declined During 2nd Covid-19 Wave, Says ICRA: BQ
• Emerging Economies 2Q GDP Forecast Steady in Past Week
• Global Funds Sell Net INR6.61B of India Stocks on Thursday: NSE
o Domestic funds buy net 1.12b rupees of stocks
• Foreign Funds Buy Net INR14.95B of Indian Equities Over Two Days
• Foreigners Buy Net INR78.2B of India Equity Derivatives Thursday
• India’s Nifty Climbs to a Record as Businesses Prepare to Reopen
• Oil Erases Losses With Demand Hopes Weighing Against Iran Risk
• Ford Sets ‘No Production Days’ on May 28, 29 at India Plant: PTI
• RBI flags risk of bubble in Indian equity markets: PTI
• Sovereign gold bonds sales fetch INR257b till March end: PTI
• Eicher Motors (EIM): 4Q net income +73% y/y to 5.26b rupees, misses est. 5.66b; revenue +33% to 29.4b rupees
• Dixon Tech India (DIXON): 4Q net income 442.6m rupees vs. 615.9m rupees q/q
• HEG (HEG): 4Q net loss 160.8m rupees Vs. loss 3.8b y/y; revenue +3% to 3.8b
• IRB Infrastructure (IRB): 4Q net income -37% y/y to 974.6m rupees, beats est. 797.8m
• Metropolis Health (METROHL): 4Q net income 613.5m rupees vs. 154.9m y/y, beats est. 602.5m
• Redington India (REDI): 4Q net income 3.03b rupees vs. 1.19b y/y, beats est. 1.62b; revenue +39% to 2.92b
• Sun Pharmaceutical (SUNP): 4Q net income 8.94b rupees vs. 4b y/y, est. 13.7b; has 4Q exceptional loss 6.73b
• UCO Bank (UCO): 4Q net income 800.3m rupees vs. 167.8m y/y; Seeks to raise up to 30b rupees
• Paytm Is Said to Target $3 Billion IPO, Largest Yet in India
o Board plans to meet Friday to formally approve the IPO
• BPCL Privatization Expected Latest by March, CFO Says
o BPCL May Buy 2m Tons/Year of Iranian Oil if Price is Right: CFO
• Top India Drugmaker Misses Profit Estimate on One-Time Cost
o U.S. sales fell in the March qtr but India rose almost 13%
• Forex Trades Helped India RBI Pay Bumper Dividend to Government
• Cyclone Inflicts $2.1 Billion in Damage in India’s West Bengal
• India FY22 Housing Demand Seen Rising 5-10% on WFH Trend: Crisil
• Oil Demand Recovery in Virus-Ravaged India Tough to Predict
• U.S. LNG Exports to India Jump; Robust Deliveries to China
• Twitter Decries India Intimidation, Will Press for Changes
• Toll Collections Declined During 2nd Covid-19 Wave, Says ICRA: BQ
• Emerging Economies 2Q GDP Forecast Steady in Past Week
• Global Funds Sell Net INR6.61B of India Stocks on Thursday: NSE
o Domestic funds buy net 1.12b rupees of stocks
• Foreign Funds Buy Net INR14.95B of Indian Equities Over Two Days
• Foreigners Buy Net INR78.2B of India Equity Derivatives Thursday
• India’s Nifty Climbs to a Record as Businesses Prepare to Reopen
• Oil Erases Losses With Demand Hopes Weighing Against Iran Risk
• Ford Sets ‘No Production Days’ on May 28, 29 at India Plant: PTI
• RBI flags risk of bubble in Indian equity markets: PTI
• Sovereign gold bonds sales fetch INR257b till March end: PTI
• Eicher Motors (EIM): 4Q net income +73% y/y to 5.26b rupees, misses est. 5.66b; revenue +33% to 29.4b rupees
• Dixon Tech India (DIXON): 4Q net income 442.6m rupees vs. 615.9m rupees q/q
• HEG (HEG): 4Q net loss 160.8m rupees Vs. loss 3.8b y/y; revenue +3% to 3.8b
• IRB Infrastructure (IRB): 4Q net income -37% y/y to 974.6m rupees, beats est. 797.8m
• Metropolis Health (METROHL): 4Q net income 613.5m rupees vs. 154.9m y/y, beats est. 602.5m
• Redington India (REDI): 4Q net income 3.03b rupees vs. 1.19b y/y, beats est. 1.62b; revenue +39% to 2.92b
• Sun Pharmaceutical (SUNP): 4Q net income 8.94b rupees vs. 4b y/y, est. 13.7b; has 4Q exceptional loss 6.73b
• UCO Bank (UCO): 4Q net income 800.3m rupees vs. 167.8m y/y; Seeks to raise up to 30b rupees
Forwarded from Books - Make India Read (Shreyansh Sheth)
My Top 10 Investment Mistakes .pdf
893.8 KB
My Top 10 Investment Mistakes
BEST RESULTS .pdf
529 KB
BEST RESULTS .pdf
MARKET WIZARD NEWSLETTER ISSUE 12.pdf
2 MB
🎯MARKET WIZARD🎯
📊 NEWSLETTER ISSUE 12
🎯Fundamental Stocks
▶️Nelcast Ltd
▶️D B Corp Ltd
▶️Reliance Industries Ltd
▶️ITC Industrial Ltd
▶️BCG Ltd
🎯Technical Stocks
▶️Arvind Fashion Ltd
▶️ BBTC Ltd - SPECIAL PICK
▶️ INTENSE TECH Ltd
▶️ KIRI INDUSTRIES Ltd
▶️ TOKYO PLAST Ltd
📍TEAM MARKET WIZARD 📍
📊 NEWSLETTER ISSUE 12
🎯Fundamental Stocks
▶️Nelcast Ltd
▶️D B Corp Ltd
▶️Reliance Industries Ltd
▶️ITC Industrial Ltd
▶️BCG Ltd
🎯Technical Stocks
▶️Arvind Fashion Ltd
▶️ BBTC Ltd - SPECIAL PICK
▶️ INTENSE TECH Ltd
▶️ KIRI INDUSTRIES Ltd
▶️ TOKYO PLAST Ltd
📍TEAM MARKET WIZARD 📍
*Bank of Baroda Ltd.* | *CMP* Rs. 84 | *M Cap* Rs. 43439 Cr | *52 W H/L* 100/36
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Net Interest Income came at Rs. 7107 Cr vs expectation of Rs. 7684 Cr, YoY Rs. 6798 Cr, QoQ Rs. 7477 Cr
Non Interest Income came at Rs. 4848 Cr vs expectation of Rs. 2528 Cr, YoY Rs. 2835 Cr, QoQ Rs. 2896 Cr
PBP came at Rs. 6266 Cr vs expectation of Rs. 5343 Cr, YoY Rs. 5121 Cr, QoQ Rs. 5069 Cr
Provisions came at Rs. 3586 Cr vs expectation of Rs. 3961 Cr, YoY Rs. 6844 Cr, QoQ Rs. 3435 Cr
Adj. PAT came at Rs. -1047 Cr vs expectation of Rs. 1044 Cr, YoY Rs. 507 Cr, QoQ Rs. 1061 Cr
PAT is lower due to one off high tax rate of 140%
Gross NPA came at Rs. 66671 Cr vs QoQ (proforma) Rs. 71784 Cr at 8.87% vs QoQ 9.63%
Net NPA came at Rs. 21800 Cr vs QoQ (non-proforma)Rs. 16668 Cr at 3.09% vs QoQ 2.39%
Share is trading at P/E of 8.6x FY22E EPS & 0.8x trailing P/Adj. BV
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Net Interest Income came at Rs. 7107 Cr vs expectation of Rs. 7684 Cr, YoY Rs. 6798 Cr, QoQ Rs. 7477 Cr
Non Interest Income came at Rs. 4848 Cr vs expectation of Rs. 2528 Cr, YoY Rs. 2835 Cr, QoQ Rs. 2896 Cr
PBP came at Rs. 6266 Cr vs expectation of Rs. 5343 Cr, YoY Rs. 5121 Cr, QoQ Rs. 5069 Cr
Provisions came at Rs. 3586 Cr vs expectation of Rs. 3961 Cr, YoY Rs. 6844 Cr, QoQ Rs. 3435 Cr
Adj. PAT came at Rs. -1047 Cr vs expectation of Rs. 1044 Cr, YoY Rs. 507 Cr, QoQ Rs. 1061 Cr
PAT is lower due to one off high tax rate of 140%
Gross NPA came at Rs. 66671 Cr vs QoQ (proforma) Rs. 71784 Cr at 8.87% vs QoQ 9.63%
Net NPA came at Rs. 21800 Cr vs QoQ (non-proforma)Rs. 16668 Cr at 3.09% vs QoQ 2.39%
Share is trading at P/E of 8.6x FY22E EPS & 0.8x trailing P/Adj. BV
*Camlin Fine Sciences Ltd.* | *CMP* Rs. 180 | *M Cap* Rs. 2297 Cr | *52 W H/L* 180/36
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Revenue from Operations came at Rs. 326.6 Cr (9.6% QoQ, 11.5% YoY) vs expectation of Rs. 288.2 Cr, QoQ Rs. 297.9 Cr, YoY Rs. 292.9 Cr
EBIDTA came at Rs. 50.4 Cr (3.6% QoQ, 47.1% YoY) vs expectation of Rs. 49.7 Cr, QoQ Rs. 48.7 Cr, YoY Rs. 34.3 Cr
EBITDA Margin came at 15.4% vs expectation of 17.2%, QoQ 16.3%, YoY 11.7%
Adj. PAT came at Rs. 15.7 Cr vs expectation of Rs. 16.7 Cr, QoQ Rs. 15.4 Cr, YoY Rs. 2.7 Cr
Quarter EPS is Rs. 1.2
Share is trading at P/E of 22.3x FY22E EPS
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Revenue from Operations came at Rs. 326.6 Cr (9.6% QoQ, 11.5% YoY) vs expectation of Rs. 288.2 Cr, QoQ Rs. 297.9 Cr, YoY Rs. 292.9 Cr
EBIDTA came at Rs. 50.4 Cr (3.6% QoQ, 47.1% YoY) vs expectation of Rs. 49.7 Cr, QoQ Rs. 48.7 Cr, YoY Rs. 34.3 Cr
EBITDA Margin came at 15.4% vs expectation of 17.2%, QoQ 16.3%, YoY 11.7%
Adj. PAT came at Rs. 15.7 Cr vs expectation of Rs. 16.7 Cr, QoQ Rs. 15.4 Cr, YoY Rs. 2.7 Cr
Quarter EPS is Rs. 1.2
Share is trading at P/E of 22.3x FY22E EPS
*Sundaram Finance Ltd. -S* | *CMP* Rs. 2498 | *M Cap* Rs. 27754 Cr | *52 W H/L* 2884/1165
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
NII came at Rs. 482.7 Cr vs expectation of Rs. 536.9 Cr, YoY Rs. 426.3 Cr, QoQ Rs. 537.8 Cr
Other Income came at Rs. 50 Cr, YoY Rs. 6 Cr, QoQ Rs. 2 Cr
PBP came at Rs. 368.9 Cr vs expectation of Rs. 399.9 Cr, YoY Rs. 281.3 Cr, QoQ Rs. 389.8 Cr
Provision came at Rs. 105.5 Cr, YoY Rs. 115.7 Cr, QoQ Rs. 69.7 Cr
PAT came at Rs. 209.2 Cr vs expectation of Rs. 212.4 Cr, YoY Rs. 130.9 Cr, QoQ Rs. 242.2 Cr
PAT was supported by higher other income.
AUM came at Rs. 30882 Cr vs YoY Rs. 29936 Cr, QoQ Rs. 31226 Cr
Gross NPA (%) came at 1.84% vs QoQ 2.79%
Net NPA (%) came at 1.01% vs QoQ 2.09%
Restructured assets totaled Rs.1,307 Cr, about 4.4% of principal outstanding.
Quarter EPS is Rs. 18.8
Share is trading at P/E of 28.6x FY22E EPS & 4.5x trailing P/BV
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
NII came at Rs. 482.7 Cr vs expectation of Rs. 536.9 Cr, YoY Rs. 426.3 Cr, QoQ Rs. 537.8 Cr
Other Income came at Rs. 50 Cr, YoY Rs. 6 Cr, QoQ Rs. 2 Cr
PBP came at Rs. 368.9 Cr vs expectation of Rs. 399.9 Cr, YoY Rs. 281.3 Cr, QoQ Rs. 389.8 Cr
Provision came at Rs. 105.5 Cr, YoY Rs. 115.7 Cr, QoQ Rs. 69.7 Cr
PAT came at Rs. 209.2 Cr vs expectation of Rs. 212.4 Cr, YoY Rs. 130.9 Cr, QoQ Rs. 242.2 Cr
PAT was supported by higher other income.
AUM came at Rs. 30882 Cr vs YoY Rs. 29936 Cr, QoQ Rs. 31226 Cr
Gross NPA (%) came at 1.84% vs QoQ 2.79%
Net NPA (%) came at 1.01% vs QoQ 2.09%
Restructured assets totaled Rs.1,307 Cr, about 4.4% of principal outstanding.
Quarter EPS is Rs. 18.8
Share is trading at P/E of 28.6x FY22E EPS & 4.5x trailing P/BV
*Divis Laboratories Ltd.* | *CMP* Rs. 4117 | *M Cap* Rs. 109293 Cr | *52 W H/L* 4205/2090
(Nirmal Bang Retail Research)
*Result is above expectations*
Revenue from Operations came at Rs. 1788.2 Cr (5.1% QoQ, 28.7% YoY) vs expectation of Rs. 1700.5 Cr, QoQ Rs. 1701.4 Cr, YoY Rs. 1389.7 Cr
EBIDTA came at Rs. 716.3 Cr (3.6% QoQ, 61.2% YoY) vs expectation of Rs. 675 Cr, QoQ Rs. 691.2 Cr, YoY Rs. 444.5 Cr
EBITDA Margin came at 40.1% vs expectation of 39.7%, QoQ 40.6%, YoY 32%
Adj. PAT came at Rs. 502 Cr vs expectation of Rs. 469.9 Cr, QoQ Rs. 470.6 Cr, YoY Rs. 388.2 Cr
Quarter EPS is Rs. 18.9
Share is trading at P/E of 45.4x FY22E EPS
(Nirmal Bang Retail Research)
*Result is above expectations*
Revenue from Operations came at Rs. 1788.2 Cr (5.1% QoQ, 28.7% YoY) vs expectation of Rs. 1700.5 Cr, QoQ Rs. 1701.4 Cr, YoY Rs. 1389.7 Cr
EBIDTA came at Rs. 716.3 Cr (3.6% QoQ, 61.2% YoY) vs expectation of Rs. 675 Cr, QoQ Rs. 691.2 Cr, YoY Rs. 444.5 Cr
EBITDA Margin came at 40.1% vs expectation of 39.7%, QoQ 40.6%, YoY 32%
Adj. PAT came at Rs. 502 Cr vs expectation of Rs. 469.9 Cr, QoQ Rs. 470.6 Cr, YoY Rs. 388.2 Cr
Quarter EPS is Rs. 18.9
Share is trading at P/E of 45.4x FY22E EPS
*Sudarshan Chemical Industries Ltd.* | *CMP* Rs. 653 | *M Cap* Rs. 4519 Cr | *52 W H/L* 730/356
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Revenue from Operations came at Rs. 576.5 Cr (13.9% QoQ, 28.4% YoY) vs expectation of Rs. 536.1 Cr, QoQ Rs. 506.4 Cr, YoY Rs. 449.1 Cr
EBIDTA came at Rs. 87.5 Cr (9.8% QoQ, 45.2% YoY) vs expectation of Rs. 86.7 Cr, QoQ Rs. 79.6 Cr, YoY Rs. 60.2 Cr
EBITDA Margin came at 15.2% vs expectation of 16.2%, QoQ 15.7%, YoY 13.4%
Adj. PAT came at Rs. 53.4 Cr vs expectation of Rs. 41.9 Cr, QoQ Rs. 39.2 Cr, YoY Rs. 27.3 Cr
Quarter EPS is Rs. 7.7
Share is trading at P/E of 28.3x FY22E EPS
(Nirmal Bang Retail Research)
*Result is in-line with expectations*
Revenue from Operations came at Rs. 576.5 Cr (13.9% QoQ, 28.4% YoY) vs expectation of Rs. 536.1 Cr, QoQ Rs. 506.4 Cr, YoY Rs. 449.1 Cr
EBIDTA came at Rs. 87.5 Cr (9.8% QoQ, 45.2% YoY) vs expectation of Rs. 86.7 Cr, QoQ Rs. 79.6 Cr, YoY Rs. 60.2 Cr
EBITDA Margin came at 15.2% vs expectation of 16.2%, QoQ 15.7%, YoY 13.4%
Adj. PAT came at Rs. 53.4 Cr vs expectation of Rs. 41.9 Cr, QoQ Rs. 39.2 Cr, YoY Rs. 27.3 Cr
Quarter EPS is Rs. 7.7
Share is trading at P/E of 28.3x FY22E EPS
*Kaveri Seed Company Ltd.* | *CMP* Rs. 750 | *M Cap* Rs. 4523 Cr | *52 W H/L* 817/360
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 64.3 Cr (-45.8% QoQ, 1.8% YoY) vs expectation of Rs. 66.7 Cr, QoQ Rs. 118.5 Cr, YoY Rs. 63.1 Cr
EBIDTA came at Rs. -15.8 Cr (-254.7% QoQ, 24.8% YoY) vs expectation of Rs. -8.6 Cr, QoQ Rs. 10.2 Cr, YoY Rs. -12.7 Cr
EBITDA Margin came at -24.6% vs expectation of -12.8%, QoQ 8.6%, YoY -20.1%
Adj. PAT came at Rs. -17.8 Cr vs expectation of Rs. -6.4 Cr, QoQ Rs. 9.1 Cr, YoY Rs. 7.6 Cr
Quarter EPS is Rs. -2.9
Share is trading at P/E of 12.7x FY22E EPS
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 64.3 Cr (-45.8% QoQ, 1.8% YoY) vs expectation of Rs. 66.7 Cr, QoQ Rs. 118.5 Cr, YoY Rs. 63.1 Cr
EBIDTA came at Rs. -15.8 Cr (-254.7% QoQ, 24.8% YoY) vs expectation of Rs. -8.6 Cr, QoQ Rs. 10.2 Cr, YoY Rs. -12.7 Cr
EBITDA Margin came at -24.6% vs expectation of -12.8%, QoQ 8.6%, YoY -20.1%
Adj. PAT came at Rs. -17.8 Cr vs expectation of Rs. -6.4 Cr, QoQ Rs. 9.1 Cr, YoY Rs. 7.6 Cr
Quarter EPS is Rs. -2.9
Share is trading at P/E of 12.7x FY22E EPS
*Unichem Laboratories Ltd.* | *CMP* Rs. 329 | *M Cap* Rs. 2316 Cr | *52 W H/L* 361/121
(Nirmal Bang Retail Research)
*Result has declined*
Revenue from Operations came at Rs. 274.1 Cr (-16% QoQ, -14.4% YoY) vs QoQ Rs. 326.3 Cr, YoY Rs. 320.2 Cr
EBIDTA came at Rs. 19 Cr (-36.8% QoQ, 42.6% YoY) vs QoQ Rs. 30.1 Cr, YoY Rs. 13.4 Cr
EBITDA Margin came at 6.9% vs QoQ 9.2%, YoY 4.2%
Adj. PAT came at Rs. -0.4 Cr vs QoQ Rs. 23.6 Cr, YoY Rs. -17.2 Cr
Quarter EPS is Rs. -0.1
Share is trading at P/E of 67.5x TTM EPS
(Nirmal Bang Retail Research)
*Result has declined*
Revenue from Operations came at Rs. 274.1 Cr (-16% QoQ, -14.4% YoY) vs QoQ Rs. 326.3 Cr, YoY Rs. 320.2 Cr
EBIDTA came at Rs. 19 Cr (-36.8% QoQ, 42.6% YoY) vs QoQ Rs. 30.1 Cr, YoY Rs. 13.4 Cr
EBITDA Margin came at 6.9% vs QoQ 9.2%, YoY 4.2%
Adj. PAT came at Rs. -0.4 Cr vs QoQ Rs. 23.6 Cr, YoY Rs. -17.2 Cr
Quarter EPS is Rs. -0.1
Share is trading at P/E of 67.5x TTM EPS
*Advanced Enzyme Technologies Ltd.* | *CMP* Rs. 458 | *M Cap* Rs. 5116 Cr | *52 W H/L* 504/149
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 133.2 Cr (-3.3% QoQ, 20.8% YoY) vs expectation of Rs. 130.2 Cr, QoQ Rs. 137.7 Cr, YoY Rs. 110.3 Cr
EBIDTA came at Rs. 54.9 Cr (-17.3% QoQ, 12.7% YoY) vs expectation of Rs. 62.5 Cr, QoQ Rs. 66.4 Cr, YoY Rs. 48.7 Cr
EBITDA Margin came at 41.2% vs expectation of 48%, QoQ 48.2%, YoY 44.2%
Adj. PAT came at Rs. 31.7 Cr vs expectation of Rs. 40.3 Cr, QoQ Rs. 43.1 Cr, YoY Rs. 31.3 Cr
Quarter EPS is Rs. 2.8
Share is trading at P/E of 27x FY22E EPS
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 133.2 Cr (-3.3% QoQ, 20.8% YoY) vs expectation of Rs. 130.2 Cr, QoQ Rs. 137.7 Cr, YoY Rs. 110.3 Cr
EBIDTA came at Rs. 54.9 Cr (-17.3% QoQ, 12.7% YoY) vs expectation of Rs. 62.5 Cr, QoQ Rs. 66.4 Cr, YoY Rs. 48.7 Cr
EBITDA Margin came at 41.2% vs expectation of 48%, QoQ 48.2%, YoY 44.2%
Adj. PAT came at Rs. 31.7 Cr vs expectation of Rs. 40.3 Cr, QoQ Rs. 43.1 Cr, YoY Rs. 31.3 Cr
Quarter EPS is Rs. 2.8
Share is trading at P/E of 27x FY22E EPS
DIVIS LAB Q4 : Net Profit up 29 % to Rs 502 cr (YOY)
Revneue Up 28 % to Rs 1788 cr
Revneue Up 28 % to Rs 1788 cr